Navigation Links
MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners
Date:4/28/2009

DENVER, CO, April 28 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH. PK) (http://www.mitcanada.ca http://www.mitinvest.ca), MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners. This private investment from our partners is an important step towards the final stage of the negotiations and a commitment towards MIT's technology and products.

This joint venture agreement will help Medical International Technologies (MIT Canada) Inc. become a world leader in the Needle-Free technology and reduce the world's dependence on needles. Moreover, it will ensure that MIT injectors become an indispensable, environmentally friendly product for single and mass vaccination, and biologics injectables for doctors and users around the world. MIT's mission is to help make the world needle-free.

This technology is the outcome of more than twenty-eight years of research and development and the driving force behind the Med-Jet(R) product line for humans and the Agro-Jet(R) product line for animals.

Medical International Technology Inc. is pleased to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

Karim Menassa, President

On Behalf of the Board of Directors

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individual and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.


'/>"/>
SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AARP Pennsylvania Pleased by House Committee Action
2. AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP
3. RADinfo SYSTEMS(TM) is Pleased to Introduce Their Newly Established Division, VETinfo SYSTEMS(TM)
4. Georgia and South Carolina Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
5. Arkansas and Missouri Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
6. Texas Care Improvement Plus Members Overwhelmingly Pleased with Special Needs Plan
7. ScentToSleep.com Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Womans World Magazine
8. Patients Pleased With Laparoscopic GERD Surgery
9. Heska Announces Q109 Results
10. Genomic Health to Announce First Quarter 2009 Financial Results and Host Conference Call on Tuesday, May 5, 2009
11. Compendia Bioscience Announces Collaboration with MDS Pharma Services to Deliver Novel Solution for Oncology Drug Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... ... June 19, 2016 is World Sickle Cell Observance Day. In an effort to ... treatments, Serenity Recovery Center of Marne, Michigan, has issued a pain management ... (SCD) is a disorder of the red blood cells, which can cause episodes of ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... and INDIANAPOLIS , June 23, ... a Lilly Diabetes Tomorrow,s Leaders Scholarship is any indication, ... winners, announced today online at www.diabetesscholars.org by ... 1 diabetes stand in the way of academic and ... the Foundation,s scholarship program since 2012, and continues to ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: